Middle East News Watch
SEE OTHER BRANDS

The latest news from the Middle East

Middle East News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.

Press releases published on April 17, 2025

Domestic Metals Provides Corporate Update and Results from Geological Reconnaissance Work and Thin Section Analysis at the Smart Creek Project, Montana

Domestic Metals Provides Corporate Update and Results from Geological Reconnaissance Work and Thin Section Analysis at the Smart Creek Project, Montana

VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. ("Domestic Metals" or the "Company") (TSXV:DMCU; OTC:DMCUF; Frankfurt: 03E) provides a corporate update and results from geological reconnaissance work and thin section …

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Robex Lodges Prospectus for IPO to Raise A$120M Ahead of ASX Listing

Robex Lodges Prospectus for IPO to Raise A$120M Ahead of ASX Listing

Not for release to US wire services or distribution in the United States Highlights: Robex Resources has lodged a prospectus with the Australian Securities and Investment Commission (ASIC) for an Initial Public Offer to raise A$120M (before costs) IPO is …

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

CAMBRIDGE, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a conference …

Eros Resources Announces Approval of Name Change and Share Consolidation

Eros Resources Announces Approval of Name Change and Share Consolidation

Vancouver, BC, April 17, 2025 (GLOBE NEWSWIRE) -- Eros Resources Corp. (TSXV: ROCK) (OTCQB: EROSF) (“Eros” or the “Company”) announces the official consolidation of its common shares on the basis of a ten (10) pre-consolidation shares for one (1) new post- …

Falcon Welcomes Bombardier Global 7500 to Its Fleet

Falcon Welcomes Bombardier Global 7500 to Its Fleet

DUBAI, United Arab Emirates, April 17, 2025 (GLOBE NEWSWIRE) -- Falcon Global 7500 offers the ultimate combination of speed, range and spaciousness. Featuring the industry’s best equipped cabin with industry-leading reliability, our proven, award-winning …

Interius BioTherapeutics to Present at Upcoming Scientific Meetings

Interius BioTherapeutics to Present at Upcoming Scientific Meetings

PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- Interius BioTherapeutics, a clinical-stage company engineering targeted, programmable vectors for the precision delivery of genetic medicines, today announced that it will present at several upcoming …

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching Pelthos’ ZELSUVMI™ ZELSUVMI is an FDA-designated novel drug and the first and only prescription medication approved …

Precore Gold Announces Appointment of Louis Gariepy  to Its Advisory Board

Precore Gold Announces Appointment of Louis Gariepy to Its Advisory Board

VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) -- Precore Gold Corp. (CSE: PRCG) (the “Company” or “Precore Gold”) is pleased to announce the appointment of Mr. Louis Gariepy, P. Eng (OIQ) to its Advisory Board as Lead Technical Advisor. Mr. …

Zymeworks to Report First Quarter 2025 Financial Results and  Host Conference Call on May 8, 2025

Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025

VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …

Verano Elevates Florida Retail Footprint to 81 Dispensaries with the Opening of MÜV New Smyrna Beach

Verano Elevates Florida Retail Footprint to 81 Dispensaries with the Opening of MÜV New Smyrna Beach

Dispensary to celebrate 420 “high holiday” opening weekend with plethora of deals and discounts available at all Florida MÜV locations Located at 763 East 3rd Avenue, MÜV New Smyrna Beach is Verano’s fourth MÜV location in Florida’s Volusia County, a …

Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award

Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award

ZUG, Switzerland, April 17, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical …

FXiBot Launches with a Precision Strategy for GBP/USD Trading

FXiBot Launches with a Precision Strategy for GBP/USD Trading

DUBAI, UAE, April 17, 2025 (GLOBE NEWSWIRE) -- FXiBot, the latest innovation in forex automation, introduces a precision-focused strategy designed to master GBP/USD trading with a disciplined, single-position approach. Where overtrading fuels risk and …

Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives

Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives

NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has continued to expand coverage for Ryoncil® (remestemcel-L), the first …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service